The antibiotic resistance series on the State of Health has discussed, at length, the policy and market dysfunctions at the heart of the antibiotic crisis. This week, Gunnar talks with Dr. Ben Chan, an Associate Research Scientist in the department of Ecology and Evolutionary Biology at Yale University, and Ella Balasa, a cystic fibrosis patient advocate who advocates for new options to treat highly antibiotic resistant bacteria. The show details a chance meeting for Dr. Chan and Ella, which led to Ella being one of the first cystic fibrosis patients in the US to dose a phage cocktail fresh out of Dr. Chan’s lab work. The two talk about what needs to happen to bring a technology out of academic to patients and how clinical research happens outside of a randomized clinical trial.

Subscribe to the State of Health on Spotify and iTunes!